Hospital Sant Pau

Barcelona 08041

2 studies enrolling now · 9 studies all time

What they study most

Acute Kidney Injury, Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, Androgen-Resistant Prostatic Cancer, Aortic Stenosis, Aortic Valve Disease, Diffuse Large B-cell Lymphoma (DLBCL), Giant Cell Tumors, Hormone Refractory Prostatic Cancer, Immune Checkpoint Inhibitor, Immunotherapy

Studies at this site

• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
• A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma — Recruiting now
• A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed
• Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
• Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib — Completed
• Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery — Stopped early
• Sorin Universal REgistry on Aortic Valve Replacement — Stopped early
• Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project — Completed